Find latest CLL videos · 100+ videos

This video is featured in the 2024 ASH Annual Meeting Insights Hub

ASH 2024 Insights: Zanubrutinib, Obinutuzumab, and Venetoclax (BOVen) in 1L CLL - 5yr Follow up, Retreatment, and MRD Kinetics

59 views
December 20, 2024
Comments 0
Login to view comments. Click here to Login